The complexity of TIM-3, characterized by its unconventional signaling, extensive-expression across various immune cell types, and interactions with multiple ligands, offers a compelling avenue for investigation in the realm of ovarian cancer immunity. This evidence concerns the gene HAVCR2 and ovarian cancer.